IL163596A0 - Cd40 splice variants, compositions for making and methods of using thesame - Google Patents
Cd40 splice variants, compositions for making and methods of using thesameInfo
- Publication number
- IL163596A0 IL163596A0 IL16359603A IL16359603A IL163596A0 IL 163596 A0 IL163596 A0 IL 163596A0 IL 16359603 A IL16359603 A IL 16359603A IL 16359603 A IL16359603 A IL 16359603A IL 163596 A0 IL163596 A0 IL 163596A0
- Authority
- IL
- Israel
- Prior art keywords
- thesame
- compositions
- making
- methods
- splice variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35887702P | 2002-02-22 | 2002-02-22 | |
PCT/IB2003/000665 WO2003070768A2 (fr) | 2002-02-22 | 2003-02-24 | Variants d'epissage cd40, compositions de fabrication et procedes d'utilisation de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
IL163596A0 true IL163596A0 (en) | 2005-12-18 |
Family
ID=27757759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16359603A IL163596A0 (en) | 2002-02-22 | 2003-02-24 | Cd40 splice variants, compositions for making and methods of using thesame |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050272050A1 (fr) |
EP (1) | EP1485480A2 (fr) |
AU (1) | AU2003206045A1 (fr) |
CA (1) | CA2477202A1 (fr) |
IL (1) | IL163596A0 (fr) |
WO (1) | WO2003070768A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005108428A2 (fr) * | 2004-02-26 | 2005-11-17 | Compugen Ltd. | Variants d'epissage de cd40 et leurs utilisations |
WO2005105840A2 (fr) * | 2004-03-26 | 2005-11-10 | Five Prime Therapeutics, Inc. | Variants de cd40 et leurs utilisations |
US20060287229A1 (en) * | 2004-07-01 | 2006-12-21 | Dani Eshel | Novel CD40 variants |
ES2641290T3 (es) | 2007-11-20 | 2017-11-08 | Ionis Pharmaceuticals, Inc | Modulación de la expresión de CD40 |
US20090162863A1 (en) * | 2007-12-13 | 2009-06-25 | Hitachi High-Technologies Corporation | Nucleic acid detection probe |
WO2009143141A1 (fr) * | 2008-05-19 | 2009-11-26 | Case Western Reserve University | Procédé de traitement de maladies à médiation par cd40 |
SI3303395T1 (sl) | 2015-05-29 | 2020-03-31 | Abbvie Inc. | Protitelesa proti CD40 in njihove uporabe |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2089229C (fr) * | 1992-02-14 | 2010-04-13 | Alejandro A. Aruffo | Recepteur cd40cr et ligands pour celui-ci |
IL130989A0 (en) * | 1999-07-20 | 2001-01-28 | Compugen Ltd | Variants of alternative splicing |
-
2003
- 2003-02-24 CA CA002477202A patent/CA2477202A1/fr not_active Abandoned
- 2003-02-24 WO PCT/IB2003/000665 patent/WO2003070768A2/fr not_active Application Discontinuation
- 2003-02-24 EP EP03702928A patent/EP1485480A2/fr not_active Withdrawn
- 2003-02-24 AU AU2003206045A patent/AU2003206045A1/en not_active Abandoned
- 2003-02-24 IL IL16359603A patent/IL163596A0/xx unknown
-
2004
- 2004-08-23 US US10/924,074 patent/US20050272050A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1485480A2 (fr) | 2004-12-15 |
WO2003070768A3 (fr) | 2004-10-07 |
CA2477202A1 (fr) | 2003-08-28 |
WO2003070768A2 (fr) | 2003-08-28 |
AU2003206045A1 (en) | 2003-09-09 |
US20050272050A1 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003298514A8 (en) | Methods and compositions using cholinesterase inhibitors | |
EP1572262A3 (fr) | Procede d'administration d'une anesthesie locale | |
AU2003284115A1 (en) | Method of delivering local anesthesia | |
AP2089A (en) | Compositions and methods for combination antiviraltherapy | |
AU154703S (en) | Set of trocars | |
EP1696910A4 (fr) | Compositions et procedes pour traiter une fibrose | |
AU2001233081A1 (en) | Composition for treatment of stress | |
AU2003271944A1 (en) | Methods for making water treatment compositions and compositions thereof | |
AU2003287443A1 (en) | Compositions and methods for pain reduction | |
IL175657A0 (en) | Derivatives of dihydronepetalactone and method for preparation | |
GB0303609D0 (en) | Novel therapeutic method and compositions | |
AP2005003316A0 (en) | Methods and compositions for immunization against HIV | |
GB0211842D0 (en) | Method of voice authentication | |
EP1492522A4 (fr) | Formulations d'ansamycine et procedes de production et d'utilisation de celles-ci | |
EP1670894B8 (fr) | Compositions comprenant divers types de facteur de transfert, procedes de preparation des compositions et methodes de traitement mettant en oeuvre les compositions | |
IL163596A0 (en) | Cd40 splice variants, compositions for making and methods of using thesame | |
EP1488046A4 (fr) | Procede de construction | |
AU2003275433A1 (en) | Compositions and methods for treating pain | |
AU2003263962A8 (en) | Tissue compositions and methods for producing same | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
GB0303600D0 (en) | Novel therapeutic method and compositions | |
AU2003202255A1 (en) | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same | |
AU2003285006A8 (en) | Method of preparation of oligosaccharides | |
GB0222736D0 (en) | Method of authentication | |
AU2003255785A1 (en) | Method of authentication |